BlackRock, Inc. 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | NGM Biopharmaceuticals, Inc. NGM |
BlackRock Inc. BLK |
3,839,879 4.600% |
-318,764 (-7.67%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
BlackRock Inc. BLK |
4,158,643 5.100% |
4,158,643 (New Position) |
Filing |